Cash-Flow King Hold: Is $5,000 a Forever Bet for Markets?
Vertex Pharmaceuticals is being pitched as a durable cash-flow king for patient investors. This piece analyzes the ca...
An overview of situations where market-cap weighted benchmarks are appropriate and practical tips for effective performance comparison.
28,411 articlesVertex Pharmaceuticals is being pitched as a durable cash-flow king for patient investors. This piece analyzes the ca...
A new income model uses a $560,000 portfolio built from covered-call ETFs, preferred shares, and BDCS to generate abo...
The Federal Housing Administration announces the resignation of Commissioner Frank Cassidy, effective June 1, ending ...
Broadcom posted a robust Q2 with AI-driven revenue rising sharply, but the stock pulled back. A bold market thesis, h...
XRP is testing a pivotal support area after a steep two-week selloff. The bounce remains fragile, keeping downside ri...
Pi Network updates its Launchpad participation model and begins SLICE testing to boost engagement. With nearly 480,00...
Bank on a nuclear surge in 2026? URNM and URA offer different routes to exposure. This piece breaks down urnm: which ...
Crypto PACs are financing GOP primaries at a rapid pace even as the Senate stalls on major crypto legislation, alteri...
Amazon’s Q1 2026 results show AWS posting rapid growth amid a surge in AI demand. With AI revenue above $15B and a $2...
David Tepper accelerates a $400 million macro bet pairing a country ETF with a memory-chip giant, underscoring what s...
J.P. Morgan's strategists raise their year-end S&P 500 view to 7,800, citing stronger earnings and resilient consumer...
A year of explosive AI-driven demand has propelled Micron to the forefront of memory chips. Now investors wonder if t...